|
|
|
|
|
|
|
|
|||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
First published online 21 September 2004
doi: 10.1242/jcs.01350
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Research Article |
1 INSERM U601, Institut de Biologie, 9 quai Moncousu, 44093 Nantes CEDEX, France
2 INSERM U533, Faculté des Sciences, 2 rue de la Houssinière, 44322, Nantes CEDEX 3, France
* Author for correspondence (e-mail: mclement{at}nantes.inserm.fr)
Accepted 8 June 2004
Sialyl-Tn (STn) is a tumor-associated carbohydrate antigen overexpressed in various carcinomas. To obtain its expression, murine carcinoma cells were transfected with the cDNA encoding ST6GalNAc I, a glycosyltransferase that acts exclusively on O-glycans. Overexpression of this enzyme led to the expected expression of cell surface STn epitopes. Surprisingly, the transfectants (STn+ cells) presented dramatic morphological changes and altered behavior. These STn+ cells lost the epithelial appearance of parental cells, became larger, more elongated and presented disorganized actin stress fibers. Additionally, their proliferation was impaired and their ability to migrate on fibronectin and hyaluronic acid was severely reduced. By contrast their adhesion on fibronectin remained unchanged. The major glycoprotein carrying the STn epitope was shown to be the integrin ß1 subunit. Anti-STn antibodies could restore migration of STn+ cells on fibronectin. A constitutively active permeant form of RhoA (TAT-RhoAVal-14) also restored motility on fibronectin of STn+ cells as well as a parental STn-cellular phenotype. These observations indicate that overexpression of ST6GalNAc I leads to a major change of the O-glycosylation of the integrin ß1 chain which in turn impairs the integrin-mediated signalling and leads to major alterations in morphology and cell behavior.
Key words: Sialyltransferase, O-glycans, Integrin, Motility, Cellular morphology
This article has been cited by other articles:
|
|
 |
|
  M. Lee, H.-J. Lee, S. Bae, and Y.-S. Lee Protein Sialylation by Sialyltransferase Involves Radiation Resistance Mol. Cancer Res., August 1, 2008; 6(8): 1316 - 1325. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Vijayakumar, H. Erdjument-Bromage, P. Tempst, and Q. Al-Awqati Role of Integrins in the Assembly and Function of Hensin in Intercalated Cells J. Am. Soc. Nephrol., June 1, 2008; 19(6): 1079 - 1091. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. T. Laughlin, J. M. Baskin, S. L. Amacher, and C. R. Bertozzi In Vivo Imaging of Membrane-Associated Glycans in Developing Zebrafish Science, May 2, 2008; 320(5876): 664 - 667. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Huang, J.-T. Liang, H.-C. Huang, T.-L. Shen, H.-Y. Chen, N.-Y. Lin, M.-I. Che, W.-C. Lin, and M.-C. Huang {beta}1,4-N-Acetylgalactosaminyltransferase III Enhances Malignant Phenotypes of Colon Cancer Cells Mol. Cancer Res., June 1, 2007; 5(6): 543 - 552. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Chiricolo, N. Malagolini, S. Bonfiglioli, and F. Dall'Olio Phenotypic changes induced by expression of {beta}-galactoside {alpha}2,6 sialyltransferase I in the human colon cancer cell line SW948 Glycobiology, February 1, 2006; 16(2): 146 - 154. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Julien, E. Adriaenssens, K. Ottenberg, A. Furlan, G. Courtand, A.-S. Vercoutter-Edouart, F.-G. Hanisch, P. Delannoy, and X. Le Bourhis ST6GalNAc I expression in MDA-MB-231 breast cancer cells greatly modifies their O-glycosylation pattern and enhances their tumourigenicity Glycobiology, January 1, 2006; 16(1): 54 - 64. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. C. Seales, G. A. Jurado, B. A. Brunson, J. K. Wakefield, A. R. Frost, and S. L. Bellis Hypersialylation of {beta}1 Integrins, Observed in Colon Adenocarcinoma, May Contribute to Cancer Progression by Up-regulating Cell Motility Cancer Res., June 1, 2005; 65(11): 4645 - 4652. [Abstract] [Full Text] [PDF]
|
|
